Acta Vet. Brno 2019, 88: 233-241
https://doi.org/10.2754/avb201988020233
Effects of antibacterial compound of Saccharomyces cerevisiae from koumiss on immune function and caecal microflora of mice challenged with pathogenic Escherichia coli O8
References
1. 2016: Effect of Lactobacillus strains on intestinal microflora and mucosa immunity in Escherichia coli O157:H7-induced diarrhea in mice. Curr Microbiol 73: 65-70
< X, Wang TT, Xu M, Evivie SE, Luo GW, Liang HZ, Yu SF, Huo GC https://doi.org/10.1007/s00284-016-1010-3>
2. 1999: Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37: 497-503
P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL
3. 2012: Health evaluation of experimental laboratory mice. Curr Protoc Mouse Biol 2: 145-165
< T, Foltz C, Karlsson E, Linton CG, Smith JM https://doi.org/10.1002/9780470942390.mo110217>
4. 2015: Screening and extracting mycocin secreted by yeast isolated from Koumiss and their antibacterial effect. J Food Nutr Res 3: 52-56
< YJ, Aorigele C, Wang CJ, Simujide H, Yang SQ https://doi.org/10.12691/jfnr-3-1-9>
5. 2017: Effects of antibacterial compound produced by Saccharomyces cerevisiae in Koumiss on pathogenic Escherichia coli O8 and its cell surface characteristics. J Integr Agr 16: 742-748
< YJ, Wang CJ, Hou WQ, Wang XS, Gali BG, Simujide H, Yang SQ, Aqima W, Zhao YF, Wu YG, Aorigele C https://doi.org/10.1016/S2095-3119(16)61516-2>
6. 2009: Evaluation of the protective effect of probiotics fed to dairy cows during a subacuteruminal acidosis challenge. Anim Feed Sci Tech 153: 278-291
< J https://doi.org/10.1016/j.anifeedsci.2009.07.001>
7. 2003: The use and resistance to antibiotics in the community. Int J Antimicrob Agents 21: 297-307
< M https://doi.org/10.1016/S0924-8579(02)00394-1>
8. 2010: Biological diversity of Saccharomyces yeasts of spontaneously fermenting wines in four wine regions: comparative genotypic and phenotypic analysis. Int J Food Microbiol 140: 239-248
< H, Zakany N, Capece A, Romano P, Sipiczki M https://doi.org/10.1016/j.ijfoodmicro.2010.03.024>
9. 2015: Drug resistance reversal potential of ursolic acid derivatives against nalidixic acid- and multidrug-resistant Escherichia coli. Chem Biol Drug Des 86: 272-283
< GR, Maurya A, Yadav DK, Khan F, Darokar MP, Srivastava KS https://doi.org/10.1111/cbdd.12491>
10. 2011: Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Appl Environ Microbiol 77: 1127-1131
< L, Livrelli V, Privat M, Denis S, Cardot JM, Alric M, Blanquet-Diot S https://doi.org/10.1128/AEM.02130-10>
11. 2012: Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins. Mol Biol Rep 39: 989-997
< HY, Wang L, Luo J, Long BG https://doi.org/10.1007/s11033-011-0824-0>
12. 2010: Saccharomyces cerevisiae strain UFMG 905 protects against bacterial translocation, preserves gut barrier integrity and stimulates the immune system in a murine intestinal obstruction model. Arch Microbiol 192: 477-484
< SV, Viana M, Santos R, Martins FS, Machado JA, Arantes RM, Nicoli JR, Correia MI, Cardoso VN https://doi.org/10.1007/s00203-010-0574-8>
13. 2008: Interaction of enterohemorrhagic Escherichia coli O157: H7 with mouse intestinal mucosa. FEMS Microbiol Lett 283: 196-202
< F, Frankel G, Phillips AD, Cooley W, Weyer U, Dugdale AHA, Woodward MJ, La Ragione RM https://doi.org/10.1111/j.1574-6968.2008.01166.x>
14. 2008: Associations between antimicrobial resistance genes in fecal generic Escherichia coli isolates from cow-calf herds in western Canada. Appl Environ Microbiol 74: 3658-3666
< SP, Waldner CL, Harel J, Boerlin P https://doi.org/10.1128/AEM.02505-07>
15. 2012: Effect of polysaccharides extract of rhizoma- atractylodis macrocephalae on thymus, spleen and cardiac indexes, caspase-3 activity ratio, Smac/DIABLO and HtrA2/Omi protein and mRNA expression levels in aged rats. Mol Biol Rep 39: 9285-9290
< L, Sun YL, Wang AH, Xu CE, Zhang MY https://doi.org/10.1007/s11033-012-1677-x>
16. 2011: Effects of yeast (Saccharomyces cerevisiae) and yeast protein concentrate on production performance of broiler chickens exposed to heat stress and challenged with Salmonella enteritidis. Anim Feed Sci Technol 168: 61-71
< S, Ghosh TK, Toshiwati, Bedford MR https://doi.org/10.1016/j.anifeedsci.2011.03.007>
17. 1998: Overview of gut flora and probiotics. Int J Food Microbiol 41: 85-101
< WH, Haberer P, Snel J, Schillinger U, Huis in’t Veld JH https://doi.org/10.1016/S0168-1605(98)00044-0>
18. 2001: Commensal host-bacterial relationships in the gut. Science 292: 1115-1118
< LV, Gordon JI https://doi.org/10.1126/science.1058709>
19. 2002: Beneficial role of koumiss intake of Mongolian Nomads. J Jpn Soc Nutr Food Sci 55: 281-285
< S, Konagaya Y https://doi.org/10.4327/jsnfs.55.281>
20. 2012: Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti inflammatory role of glucan fractions. Plos One 7: e40648
< S, Habib K, Maggiotto F, Pignede G, Vandekerckove P, Maes E, Dubuquoy L, Fontaine T, Guerardel Y, Poulain D https://doi.org/10.1371/journal.pone.0040648>
21. 2011: Physiological and metabolic diversity in the yeast Kluyveromyces marxianus. Antonie Van Leeuwenhoek 100: 507-519
< MM, Burke N, Karreman R, Wolfe KH, O’Byrne CP, Morrissey JP https://doi.org/10.1007/s10482-011-9606-x>
22. 2008: B lymphocytes: how they develop and function. Blood 112: 1570-1580
< TW, Tedder TF https://doi.org/10.1182/blood-2008-02-078071>
23. 2006: Mucosal immunization with surface-displayed severe acute respiratory syndrome coronavirus spike protein on Lactobacillus casei induces neutralizing antibodies in mice. J Virol 80: 4079-4087
< JS, Poo H, Han DP, Hong SP, Kim K, Cho MW, Kim E, Sung MH, Kim CJ https://doi.org/10.1128/JVI.80.8.4079-4087.2006>
24. 2004: Antibacterial resistance worldwide: causes, challenges and responses. Nat Med 10: S122-S129
< SB, Marshall B https://doi.org/10.1038/nm1145>
25. 2015: Prevalence and patterns of antimicrobial resistance among Escherichia coli isolated from Zambian dairy cattle across different production systems. Sci Rep 5: 12439
< G, Bessell PR, Muma JB, McAteer SP, Chase-Topping ME, Gibbons J, Stevens MP, Gally DL, deC Bronsvoort BM https://doi.org/10.1038/srep12439>
26. 1996: Saccharomyces unisporus as the principal alcoholic fermentation microorganism of traditional koumiss. J Dairy Res 63: 327-331
< G, Zambonelli C, Grazia L, Kamesheva GK, Shigaeva MK https://doi.org/10.1017/S0022029900031836>
27. 2012: Detection and identification of wild yeast in Koumiss. Food Microbiol 31: 301-308
< ZS, Yang XJ, Yuan HL https://doi.org/10.1016/j.fm.2012.04.004>
28. 2006: Microflora in Hurunge, traditional starter culture, from Inner Mongolia, China. Anim Sci J 77: 235-241
S, Burentegusi, Yu B
29. 2004: Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 50: 1918-1927
< S, Fujimoto M, Hasegawa M, Takehara K, https://doi.org/10.1002/art.20274>
30. 2006: T-cell costimulation - biology, therapeutic potential, and challenges. N Engl J Med 355: 973-975
< AH, Abbas AK https://doi.org/10.1056/NEJMp068087>
31. 2012: Occurrence and characteristics of virulence genes of Escherichia coli strains isolated from healthy dairy cows in Inner Mongolia, China. Braz J Microbiol 43: 528-534
H, Aorigele C, Wang CJ, Li Y, Bai T
32. 2002a: Supplemental fructooligosaccharides and mannanoligosaccharides influence immune function, ileal and total tract nutrient digestibilities, microbial populations and concentrations of protein catabolites in the large bowel of dogs. J Nutr 132: 980-989
< KS, Grieshop CM, Flickinger EA, Bauer LL, Healy HP, Dawson KA, Merchen NR, Fahey GC Jr https://doi.org/10.1093/jn/132.5.980>
33. 2002b: Effects of supplemental fructooligosaccharides plus mannanoligosaccharides on immune function and ileal and fecal microbial populations in adult dogs. Arch Tierernahr 56: 309-318
< KS, Grieshop CM, Flickinger EA, Healy HP, Dawson KA, Merchen NR, Fahey GC Jr https://doi.org/10.1080/00039420214344>
34. 2012: Antimicrobial drug resistance in Escherichia coli from humans and food animals, United States, 1950-2002. Emerg Infect Dis 18: 741-749
< DA, Zhao S, Tong E, Ayers S, Singh A, Bartholomew MJ, McDermott PF https://doi.org/10.3201/eid1805.111153>
35. 2015: Comparison of three patterns of feed supplementation with live yeast on postweaning diarrhea, health status, and blood metabolic profile of susceptible weaning pigs orally challenged with F4ac. J Anim Sci 93: 2225-2233
< P, Colombo M, Priori D, Fontanesi L, Galimberti G, Calò G, Motta V, Latorre R, Fanelli F, Mezzullo M, Pagotto U, Gherpelli Y, D’Inca R, Bosi P https://doi.org/10.2527/jas.2014-8539>
36. 2015: Dietary supplementation with yeast product improves intestinal function, and serum and ileal amino acid contents in weaned piglets. Livest Sci 171: 20-27
< X, Yang HS, Li B, Liu G, Huang RL, Li FN, Liao P, Zhang YZ, Nyachoti CM, Deng D https://doi.org/10.1016/j.livsci.2014.10.012>
37. 2011: Saccharomyces cerevisiae decreases inflammatory responses induced by F4(+) enterotoxigenic Escherichia coli in porcine intestinal epithelial cells. Vet Immunol Immunopathol 141: 133-138
< G, Meurens F, Berri M, Chevaleyre C, Melo S, Auclair E, Salmon H https://doi.org/10.1016/j.vetimm.2011.01.018>